IoN News Archive (2012)

Hereditary Whispering Dystonia gene identified

Publication date:

A genetic study at UCL Institute of Neurology has identified the gene responsible for a rare form of dystonia called ‘hereditary whispering dysphonia’ or DYT4. The study found that a mutation in the autoregulatory domain of the β-tubulin 4a gene (TUBB4a) is responsible for this disease which is known to affect a large family who emigrated to Australia from the UK in the late 19th century.

This unusual form of dystonia is characterised by a progressive limb and cervical dystonia together with a severe dysphonia which resulted in most of the affected individuals being unable to speak and who exhibited an unusual ‘hobby horse’ gait. This was first reported by the late Neville Parker in 1985 who instigated a collaboration with Anita Harding to try to identify the genetic cause of this disease in this family. Using the exome sequencing platform at ION together with a robust genetic linkage study, a team led by Prof Henry Houlden has identified the causative gene, with the results now published in the Annals of Neurology.

The mutation is located within a very small region of the TUBB4a protein that is important in auto-regulating the levels of TUBB4a mRNA. As part of previous work published in 1988 in Nature, it was shown that mutations in this region result in a loss of this autoregulatory function. This disease mechanism has not hitherto been reported and provides further insight into the pathogenesis of dystonia in general.

Professor Nicholas Wood appointed as neuroscience programme director for UCLH NIHR Biomedical Research Centre (BRC)

Publication date:

Professor Wood holds the Galton Chair in Genetics at UCL and has been a Professor at the Institute of Neurology since 2001. His group have made major contributions to our understanding of the genetic basis of neurological disease.
Professor Wood is very excited at the prospect of helping the NIHR BRC deliver its ambitious programme of experimental Medicine and in particular the opportunities it presents to the Institute of Neurology. 
"It seems important to me that in translating medical discoveries that we address fundamental issues based on the biology of neurological disease, and use the human disease as the model system to be studied" said Professor wood.

UCL neuroscientists awarded highly competitive ERC Advanced Grants

Publication date:

Congratulations to Professors Dmitri Rusakov (UCL Institute of Neurology), Robin Ali (UCL Institute of Ophthalmology) and Patrick Haggard (UCL Institute of Cognitive Neuroscience), who have all recently been awarded European Research Council (ERC) Advanced Grants. These highly competitive research grants are among the most sought after Principal Investigator awards offered from the ERC, and as stated on the ERC’s website: “allow exceptional established research leaders of any nationality and any age to pursue ground-breaking, high-risk projects that open new directions in their respective research fields or other domains.”

Belgian Stroke Council Award to UCL student

Publication date:

Dr Andreas Charidimou, a PhD student at the UCL Institute of Neurology, has been awarded the 2012 Belgian Stroke Council Award, for his work "Spectrum of transient focal neurological episodes in cerebral amyloid angiopathy: multicentre MRI cohort study and meta-analysis", a collaborative study undertaken in the UK and Belgium.

Drugs could provide new treatment for epilepsy

Publication date:

New drugs derived from components of a specific diet used by children with severe, drug-resistant epilepsy could offer a new treatment, according to research published today in the journal Neuropharmacology.

Breakthrough in the treatment of drug-resistant epilepsy

Publication date:

Researchers at the UCL Institute of Neurology have made a breakthrough in the treatment of drug-resistant epilepsy.  They used gene therapy in an experimental model of epilepsy to allow over-excitable neurons to be inhibited by light. When they shone a laser via an optical fibre into the epileptic brain region where the gene therapy was delivered, the seizures were rapidly suppressed. For long-term treatment they used a different gene therapy to make neurons in the epileptic brain regions less excitable. This treatment both prevented the development of epilepsy, and also progressively stopped seizures when delivered after epilepsy was already established. These treatments had no detectable effects on normal behaviour. Although at an early stage, these new treatments could eventually be used in people with epilepsy that cannot be controlled by medication and where the site of initiation of the seizures can be defined using high-resolution electrical mapping.

UCL Institute of Neurology enters gene-editing research collaboration with Horizon Discovery

Publication date:

Professor Sarah Tabrizi, UCL Institute of Neurology and principal investigator of the TRACK-HD study, discusses a new research partnership between the Institute and Horizon Discovery, a technology company that provides researchers with tools to support translational genomics research. Read more: Genetic Engineering and Biotechnology News

Lifetime achievement award for Professor Thompson’s MS work

Publication date:

Professor Alan Thompson

Professor Alan Thompson, Dean of the Faculty of Brain Sciences, has been awarded a lifetime Honorary Membership from the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) at its 28th Congress on 13 October 2012 in Lyon, France. This is the first time this award has been given in the 28 year history of the largest international multiple sclerosis (MS) organisation and reflects Professor Thompson’s outstanding international reputation within the field of MS research and his extraordinary contributions to ECTRIMS, an organization which brings together European researchers in MS and connects MS researchers worldwide.

New biography of Gowers released

Publication date:

Gowers Book cover

New Gowers’ biography released

A new book chronicling the life of distinguished clinical neurologist, William Richard Gowers, was launched yesterday at Queen Square at the Third International Workshop on Functional Neurosurgery. William Richard Gowers (1845-1915): Exploring the Victorian Brain is co-authored by UCL Institute of Neurology’s Professor Andrew Lees, Ann Scott, Gowers great granddaughter, and Mervyn Eadie, a neurologist from Brisbane.

Repurposed cardiac sodium channel blocker brings significant benefit for patients with a rare neuromuscular disease

Publication date:

An international multi-centred trial published in the leading medical journal JAMA (The Journal of the American Medical Association) this week, demonstrates a significant treatment benefit using the repurposed cardiac drug, mexiletine, in a genetically stratified cohort of patients with the rare genetic neurological disorder, non-dystrophic myotonia. Professor Michael Hanna, Director of the MRC Centre for Neuromuscular Diseases led the UCL team including MRC clinical training fellow Dr Dipa Raja Rayan as the top recruiting site in this international trial. 

Toxic protein build-up in blood shines light on fatal brain disease

Publication date:


A new light-based technique for measuring levels of the toxic protein that causes Huntington’s disease (HD) has been used to demonstrate that the protein builds up gradually in blood cells. Published today (17th) in the Journal of Clinical Investigation, the findings shed light on how the protein causes damage in the brain, and could be useful for monitoring the progression of HD, or testing new drugs aimed at suppressing production of the harmful protein.

Professor Lees receives prestigious German Society of Neurology award

Publication date:

Andrew Lees

Professor Andrew Lees has been awarded the German Society of Neurology’s 2012 Dingebauer Prize for outstanding scientific attainment in the field of Parkinson's disease and Neurodegenerative Disorders. Prof Lees is to receive the award on 27th September 2012, during the 85th congress meeting in Hamburg.

Cause of Alternating Hemiplegia identified

Publication date:

An international consortium of scientists, led jointly by researchers at UCL’s Institute of Neurology and Duke University, USA, has identified the specific genetic mutation that causes Alternating Hemiplegia, a rare neurological condition affecting an estimated one child in every million. Using the newest genetic technology, next-generation sequencing, the study published in Nature Genetics, showed that de novo mutations in the gene ATP1A3 cause the condition (de novo mutations are genetic mutations not present in the parents’ genes).

Dr John Morgan-Hughes

Publication date:

It was with great sadness that we learned of the death of Dr John Morgan-Hughes.

John retired in 1997, after some thirty years at Queen Square during which he helped establish a major UK diagnostic and research muscle laboratory and also a world-class mitochondrial research group.  He received a lifetime achievement award from the World Federation of Neurology in 2002, and the ABN Medal in 2008 for distinguished contributions to neurology.  He died suddenly on Thursday, 2nd August.

Results from stroke treatment study are in top 10 of Lancet’s most highly cited papers

Publication date:

Xray picture after injection of dye into the carotid artery showing severe carotid artery narrowing in the left hand figure (arrow). The right hand figure shows the appearances after the insertion of a metallic stent across the narrowing

A paper highlighting early results from the International Carotid Stenting Study (ICSS), a UCL-led multi-centre clinical trial which compared two treatments for carotid narrowing was recently listed in the Lancet as one of their ten most cited papers in 2010-2011. Narrowing of one of the carotid arteries in the neck (stenosis), which supply blood to the brain, is one of the major causes of stroke and is usually caused by deposits of fat in the wall of the artery, known as atherosclerosis.

Skin patch improves attention span in stroke patients

Publication date:

Professor Masud Husain

Researchers in the Department of Brain Repair and Rehabilitation have found that giving the drug rotigotine as a skin patch can improve inattention in some stroke patients.

Genetic study identifies treatable pathway in childhood motor neuron disease

Publication date:

High dose riboflavin therapy

A genetic study based at UCL Institute of Neurology and the NIH in the United States has identified two riboflavin transporter genes that are defective in children with a type of motor neuron disease called Brown-Vialetto van Laere syndrome.

Awards and congratulations

Publication date:

Professor Cathy Price

Extracts from the Provost's newsletter.

"Warmest congratulations this week to:

Medical Photographer Wins Wellcome Image Awards

Publication date:


We are very pleased to announce that at the Wellcome Image Awards 2012 ceremony which took place in London last night Robert Ludlow, medical photographer at the UCL Institute of Neurology, UCLH National Hospital for Neurology and Neurosurgery Medical Illustration Unit was named as the overall winner.

Prestigious Junior Investigator Award for stroke research

Publication date:

Dr Charidimou

Congratulations to Dr Andreas Charidimou who has been awarded a prestigious Junior Investigator Award for outstanding research in stroke by a young investigator at the  XXI European Stroke Conference 2012.

Unlocking the mysteries of the mind

Publication date:

Professor Martin Rossor

Like cancer and HIV decades before, the solution to stopping dementia in its tracks has remained stubbornly intransigent. But there is hope.

The race to find a cure for dementia has never been more critical: within ten years there will be around one million people in the UK with this devastating condition – many of whom will spend their last few years severely impaired and dependent on others for care.

The NHNN and UCL Institute of Neurology are at the research epicentre and have recently been awarded grants totaling over £30 million.

Official unveiling of Neuroimaging Centre

Publication date:

Professor Tarek Yousry and Theresa Dauncey, chief executive of The National Brain Appeal with Mr Giles Du Boulay

A new neuroimaging analysis centre which will radically improve the speed of radiological diagnosis of neurological disease and pioneer research has been officially opened.

Professor Simon Shorvon appointed  Harveian librarian at the Royal College of Physicians

Publication date:

Congratulations to Simon Shorvon, professor of clinical neurology at the UCL Institute of Neurology (Department of Clinical and Experimental Epilepsy), who has been appointed Harveian librarian at the Royal College of Physicians

Parliamentary Group Visit the Institute

Publication date:


Members of the All-party Parliamentary Group on Parkinson’s disease visited the UCL Institute of Neurology today to see at first hand the research being done at UCL to understand the causes of Parkinson’s and to develop novel treatments for the disease.

Prestigious European Science Foundation networking grant awarded to Institute of Neurology professor

Publication date:

Congratulations to Professor Xavier Golay (Department of Brain Repair & Rehabilitation), who has been awarded a networking grant from the European Science Foundation COST office, the first grant of this kind awarded to UCL. The prestigious award will be used to support the Arterial Spin Labelling (ASL) Initiative in Dementia (AID) Action network, which aims to coordinate research in this area and optimise the use of facilities already existing in Europe. The network, which runs for four years, held its first networking event with the official Kick-Off Meeting in Brussels in December 2011.

Read more>> European Institute for Biomedical Imaging Research (see page 30) and COST website

International project to determine vascular contribution to neurodegeneration begins

Publication date:

18 April 2012

Congratulations to UCL Institute of Neurology scientists, Dr David Werring and Professor Nick Fox, who are part of an international team of scientists that has recently been awarded funding from the Centres of Excellence in Neurodegeneration (CoEN) to study how vascular disease contributes to neurodegenerative disease. The project, titled Standards for Determining the Vascular Contribution to Neurodegeneration, aims to create a common, albeit expert set of definitions and terminology to describe neuroimaging findings related to diseases affecting brain small vessels. These diseases, including hypertensive arteriopathy and cerebral amyloid angiopathy, are among the commonest to affect the brain and are key causes of stroke and dementia.

Prime Minister visits UCL Institute of Neurology

Publication date:

David Cameron at the IoN

UK Prime Minister David Cameron has visited the Dementia Research Centre at UCL as part of this morning’s government announcement that dementia research funding will be doubled to £66 million by 2015.

Professor Ray Dolan gives the prestigious Alan Turing Lecture

Publication date:

Professor Ray Dolan (Wellcome Department of Imaging Neuroscience) last month gave the prestigious IET/BCS Alan Turing Lecture for 2012.

The Performing Brain – A moving story? Friday 16th March

Publication date:

IoN researchers will be taking part in an interactive evening of neuroscience, music and dance aimed at all ages, being held at the British Library on Friday 16th March

Are we hard wired to be rebellious?

Publication date:

As reported in the Daily Mail:

"Scientists have discovered for the first time that being rebellious may be hard-wired in our brains."

Detecting stroke

Publication date:

Listen to Dr David Werring from UCL Institute of Neurology and the National Hospital for Neurology and Neurosurgery’s Stroke Research Group, as he discusses the importance of recognising cerebral amyloid angiopathy, a neurological condition that doctors believe increases the risk of haemorrhagic stroke and dementia.

Queen Square Clinical Trial Centre launched

Publication date:

The UCL Institute of Neurology has now opened the Queen Square Clinical Trial Centre (QSCTC).

The aim of the centre is to increase clinical trial activity in neuroscience by supporting and facilitating research and by linking with the newly established UCL Clinical Trials Unit (CTU), led by Dr. Ann-Marie Swart and working closely with the Central East London (CEL) Comprehensive Local Research Network (CLRN), current neurological disorders lead, Professor Alan Thompson.

New funding to preserve unique archives

Publication date:

The Gowers library in 1951

The Queen Square Library has been awarded a grant of £82k from the Wellcome Trust to catalogue and preserve the collections of case notes and films held as part of the Queen Square Archive. Significant work on the archives has already been carried out as part of the recent £1m refurbishment of the Library, funded by the National Brain Appeal and the Brain Research Trust, which included the creation of a base for the archives of the National Hospital and a museum.  A web site is now available providing access to results of the work carried out to date.

Major new funding for research into epilepsy is announced

Publication date:

Professor Sanjay Sisodiya

The EpiPGX Consortium, involving 15 partners from 8 countries, has received almost €6 million funding from the European Union FP7 programme to investigate the genetic basis of responses to antiepileptic drugs (AEDs) in epilepsy.

Over 50,000,000 people across the world have epilepsy. For many people, AEDs are simply not available, or the choice is extremely limited. In other countries, several AEDs are available to be prescribed, but the evidence guiding choice of drug for an individual patient is very limited. The EpiPGX Consortium will explore the influence of genetic variation on responses, both desirable and undesirable, to AEDs, aiming to identify genetic variants that will guide treatment choices at the individual level.

The Consortium is coordinated by Professor Sanjay Sisodiya, UCL Institute of Neurology (Department of Clinical and Experimental Epilepsy), with the following partners: Université Libre de Bruxelles (Belgium), Istituto Giannina Gaslini (Italy), Eberhard Karls Universitaet Tuebingen (Germany), Stichting Epilepsie Instellingen Nederland (The Netherlands), Universitaetsklinikum Bonn (Germany), Royal College of Surgeons in Ireland (Ireland), Belfast Health and Social Care Trust (UK), Islensk Erfdagreining EHF (Iceland), Universite Du Luxembourg (Luxembourg), Universitair Medisch Centrum Utrecht (The Netherlands), The University of Liverpool (UK), Imperial College of Science, Technology and Medicine (UK), University of Glasgow (UK) and GABO:mi Gesellschaft fur Ablauforganisation:milliarium mbH & Co. KG (Germany).

The Consortium welcomes collaboration. Please contact for further information.

Professor Ray Dolan elected Fellow of the APS

Publication date:

Professor Ray Dolan

Professor Ray Dolan has been elected a Fellow of the Association for Psychological Science (APS) for “sustained outstanding contributions to the science of psychology”.

New Years Honours

Publication date:

Professor Clare Fowler

We are delighted to announce that Professor Clare Fowler, UCL Professor of Uro-Neurology at the Institute and Honorary Consultant Uro-Neurologist at the NHNN, UCLH Trust, has been awarded a CBE in the New Year Honours List "for services to Uro-Neurology".

Brain Implant Cures Woman's Tourette's Tics

Publication date:

A patient who is part of the first first UK trial to evaluate the impact of 'deep brain stimulation' on Tourette's - a collaboration between the UCL Institute of Neurology (Unit of Functional Neurosurgery) and the National Hospital of Neurology and Neurosurgery - has experienced a dramatic recovery.

Search UCL News